Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Baudax Bio, Inc.

Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
From Baudax Bio, Inc.
Via Globe NewsWire
Tickers BXRX
Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery
From Baudax Bio, Inc.
Via Globe NewsWire
Tickers BXRX
Baudax Bio Announces Closing of $5 Million Public Offering
From Baudax Bio, Inc.
Via Globe NewsWire
Tickers BXRX
Baudax Bio Announces Pricing of $5 Million Public Offering
From Baudax Bio, Inc.
Via Globe NewsWire
Tickers BXRX
Baudax Bio Announces 1-for-40 Reverse Stock Split
From Baudax Bio, Inc.
Via Globe NewsWire
Tickers BXRX
Baudax Bio Reports Third Quarter 2022 Financial Results and Business Highlights
From Baudax Bio, Inc.
Via Globe NewsWire
Tickers BXRX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.